Cormedics

Recent Finacing

Equity

Recent Raise

$0.8M

Cormedics develops intrapericardial access tools and therapies, including the minimally invasive PeriPort, to deliver targeted drug, cell, gene, and device treatments across the epicardial surface for cardiac conditions.